Nevirapine-Induced Stevens–Johnson Syndrome in an HIV-Infected Patient: A Case Report From Uganda
Year: 2025
Type: article
Study design: Case Report
Abstract: Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is widely prescribed in antiretroviral therapy (ART) for HIV treatment. Although effective, it is associated with rare but severe adverse drug reactions, including Stevens-Johnson syndrome (SJS), a life-threatening mucocutaneous disorder. This case report describes a Middle age HIV-positive man who developed SJS following nevirapine initiation, highlighting the importance of timely recognition, management, and the need for clinician vigilance to prevent adverse outcomes in antiretroviral therapy.
Authors: Mohamed Jayte, Yahye Jama, Lubega Athanus
Institution: Kampala International University
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,320
OpenAlex ID: W4407551772
